首站-论文投稿智能助手
典型文献
The effects of inactivated SARS-CoV -2 vaccination andsubsequent infection of pregnant mice on the behaviors of offspring
文献摘要:
The mass inoculation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines to induce herd immunity is one of the most effective measures we can deploy in the fight against coronavirus disease 2019 (COVID-19). Pregnant women are prone to a higher risk of COVID-19, and maternal infection is a risk fac-tor for a range of neurological disorders leading to abnormal behavior in adulthood. However, there are limited clinical data to support whether vaccination or infection post-immunization in pregnant women can affect the behavioral cognition of fetuses in adulthood. In this study, human angiotensin-converting enzyme 2 pregnant mice (F0 generation) were immunized with CoronaVac and then infected with SARS-CoV-2. Subsequently, we analyzed the behavioral cognition of their adult offspring (F1 gen-eration) using the open-field test and Morris water maze test. The adult F1 generation did not exhibit any impairments in spontaneous locomotor activity or spatial refer-ence memory.
文献关键词:
作者姓名:
Kaili Lin;Meixuan Liu;Lu Sun;Hongwei Qiao;Shunyi Wang;Sidan Pan;Hanjun Fu;Jingzhu Wang;Qiang Wei;Hong Gao
作者机构:
Institute of Laboratory Animal Science,Chinese Academy of Medical Sciencesand Comparative Medicine Center,Peking Union Medical College,Beijing,China
引用格式:
[1]Kaili Lin;Meixuan Liu;Lu Sun;Hongwei Qiao;Shunyi Wang;Sidan Pan;Hanjun Fu;Jingzhu Wang;Qiang Wei;Hong Gao-.The effects of inactivated SARS-CoV -2 vaccination andsubsequent infection of pregnant mice on the behaviors of offspring)[J].动物模型与实验医学(英文),2022(05):430-435
A类:
andsubsequent
B类:
effects,inactivated,SARS,CoV,vaccination,infection,pregnant,mice,behaviors,offspring,mass,inoculation,severe,acute,respiratory,syndrome,coronavirus,vaccines,induce,herd,immunity,most,effective,measures,can,deploy,fight,against,disease,Pregnant,women,are,prone,higher,risk,maternal,fac,range,neurological,disorders,leading,abnormal,adulthood,However,there,limited,clinical,data,support,whether,post,immunization,affect,behavioral,cognition,fetuses,In,this,study,human,angiotensin,converting,enzyme,F0,generation,were,immunized,CoronaVac,then,infected,Subsequently,analyzed,their,using,open,field,test,Morris,water,maze,did,not,exhibit,any,impairments,spontaneous,locomotor,activity,spatial,refer,ence,memory
AB值:
0.640022
相似文献
SARS-CoV-2 involvement in central nervous system tissue damage
Muhammad Ali Haidar;Zaynab Shakkour;Mohammad Amine Reslan;Nadine Al-Haj;Perla Chamoun;Karl Habashy;Hasan Kaafarani;Shima Shahjouei;Sarah H.Farran;Abdullah Shaito;Esber S.Saba;Bassam Badran;Mirna Sabra;Firas Kobeissy;Maya Bizri-Department of Biochemistry and Molecular Genetics,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Faculty of Health Sciences,University of Balamand,Beirut,Lebanon;Faculty of Medicine,University of Balamand,Koura,Lebanon;Faculty of Science,Lebanese University,Baabda,Lebanon;Program for Neurotrauma,Neuroproteomics&Biomarkers Research,Departments of Emergency Medicine,University of Florida,Gainesville,FL,USA;Department of Pathology and Laboratory Medicine,American University of Beirut Medical Center,Beirut,Lebanon;Biomedical Research Center,Qatar University,Doha,Qatar;Department of Experimental Pathology,Immunology and Microbiology,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Laboratory of Cancer Biology and Molecular Immunology,Faculty of Sciences I,Lebanese University,Hadath,Beirut,Lebanon;Faculty of Medicine,Lebanese University,Neuroscience Research Center(NRC),Beirut,Lebanon;Neuroscience Institute,Neurology Department,Geisinger Health System,PA,USA;Department of Psychiatry,American University of Beirut,Beirut,Lebanon
Potential medicinal plants involved in inhibiting 3CLpro activity:A practical alternate approach to combating COVID-19
Fan Yang;Xiao-lan Jiang;Akash Tariq;Sehrish Sadia;Zeeshan Ahmed;Jordi Sardans;Muhammad Aleem;Riaz Ullah;Rainer W.Bussmann-The Medical Center of General Practice,Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu 610041,Sichuan Province,China;Xinjiang Institute of Ecology and Geography,Chinese Academy of Sciences,Urumqi 830041,Xinjiang Uygur Autonomous Region,China;Department of Biological Sciences,University of Veterinary and Animal Sciences,Ravi Campus,Pattoki 55300,Pakistan;Consejo Superior de Investigaciones Científicas,Global Ecology Unit,Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Cientificas-Universitat Autònoma de Barcelona,Bellaterra,Barcelona 08193,Catalonia,Spain;Centre for Ecological Research and Forestry Applications,Cerdanyola del Vallès 08193,Catalonia,Spain;Department of Pharmacognosy,College of Pharmacy,King Saud University,Riyadh 11451,Saudi Arabia;Department of Ethnobotany,Institute of Botany,Ilia State University,Tbilisi 0105,Georgia
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。